Endometriosis

August 5th 2022

Myovant Sciences and Pfizer announces the US Food and Drug Administration has approved Myfembree (relugolix combination tablets) for the once-daily treatment of moderate-to-severe endometriosis-associated pain.

July 22nd 2022

Women with endometriosis had a 34% greater risk of stroke than women without the chronic inflammatory gynecological condition, according to an analysis of the Nurses Health Study II.

June 17th 2022

A review of magnetic resonance imaging (MRI) for diagnosing endometriosis and related diseases in the Korean Journal of Radiology has found that the medical imaging technique can help in the early and accurate diagnosis of ovarian endometriotic cysts and deep infiltrating endometriosis (DIE), while avoiding the need for invasive procedures and radiation exposure, due to MRI’s high contrast and objectivity.

June 14th 2022

Most studies conclude that dietary interventions positively impact endometriosis, according to a systematic review in the journal Reproductive Sciences.